GEODE CAPITAL MANAGEMENT, LLC
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in RXRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$37,684,507
-$7,036,582 QoQ
Shares Held
12,275,084
+12.3% QoQ
Ownership
2.32%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. RXRX ranks #86 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,684,507 | 12,275,084 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,721,089 | 10,934,252 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $46,962,957 | 9,623,557 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $39,348,624 | 7,776,408 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $34,088,654 | 6,443,980 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $41,149,127 | 6,087,149 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $35,796,293 | 5,431,911 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $35,819,310 | 4,775,908 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $34,408,115 | 3,451,165 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $32,794,212 | 3,325,985 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $24,010,978 | 3,138,690 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $20,984,298 | 2,809,143 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $18,299,038 | 2,743,484 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,122,699 | 2,609,948 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $24,813,363 | 2,332,083 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,258,807 | 1,505,996 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,263,292 | 1,293,756 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $22,182,613 | 1,294,957 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $12,939,236 | 562,331 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $18,138,638 | 496,949 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||